Skip to main content
Erschienen in: Diabetologia 11/2007

01.11.2007 | Article

Influence of gestational diabetes on the long-term control of glucose tolerance

verfasst von: G. Seghieri, F. Tesi, R. Anichini, A. De Bellis, E. Barsotti, A. Mari, E. Ferrannini

Erschienen in: Diabetologia | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Gestational diabetes (GDM) carries a high risk of subsequent diabetes. We asked what impact prior GDM has on beta cell function and insulin action in women who maintain normal glucose tolerance (NGT) for a long time.

Methods

Ninety-one women with NGT (aged 41 ± 8 years, mean±SD) were studied (by mathematical modelling of the C-peptide response to an OGTT) 7 [6] years (median [interquartile range]) after the index pregnancy, during which 52 had GDM (pGDM) and 39 had NGT (pNGT). In all women an OGTT had also been performed at 29 ± 3 weeks of the index pregnancy.

Results

Women with pGDM were matched with women with pNGT for age, familial diabetes, time and weight gain since index pregnancy, parity, BMI (25.4 ± 3.9 vs 26.8 ± 6.4 kg/m2), and fasting (4.64 ± 0.56 vs 4.97 ± 0.46 mmol/l) and 2 h plasma glucose levels (5.91 ± 1.14 vs 5.91 ± 1.21 mmol/l). Nonetheless, fasting (49 [29] vs 70 [45] pmol min−1 m−2, p < 0.001) and total insulin secretion (32 [17] vs 48 [21] nmol m−2, p < 0.0001) and beta cell glucose sensitivity (slope of the insulin secretion/plasma glucose concentration–response function) (95 [71] vs 115 [79] pmol min−1 m−2 (mmol/l)−1, p = 0.025) were reduced in the pGDM group compared with the pNGT group, while insulin sensitivity was preserved (424 [98] vs 398 [77] ml min−1 m−2). At index pregnancy, women with pGDM and those with pNGT had similar age and BMI. However, both insulin sensitivity (359 [93] vs 417 [92] ml min−1 m−2, p = 0.0012) and the insulin/glucose incremental area ratio (an empirical index of beta cell function; 98 [74] vs 138 [122] pmol/mmol, p = 0.028) were reduced in women with pGDM.

Conclusions

Even in women who maintain normal insulin sensitivity, impaired beta cell function is carried over into the NGT status several years after a GDM pregnancy.
Literatur
1.
Zurück zum Zitat Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 25:1862–1868CrossRef Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 25:1862–1868CrossRef
2.
Zurück zum Zitat Kjos SL, Buchanan TA, Greenspoon JS, Montoro M, Bernstein GS, Mestman JH (1990) Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months postpartum. Am J Obstet Gynecol 163:93–98CrossRef Kjos SL, Buchanan TA, Greenspoon JS, Montoro M, Bernstein GS, Mestman JH (1990) Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months postpartum. Am J Obstet Gynecol 163:93–98CrossRef
3.
Zurück zum Zitat Buchanan TA, Catalano PM (1995) The pathogenesis of GDM: implications for diabetes after pregnancy. Diabetes Rev 4:584–601 Buchanan TA, Catalano PM (1995) The pathogenesis of GDM: implications for diabetes after pregnancy. Diabetes Rev 4:584–601
4.
Zurück zum Zitat Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 21:103–113CrossRef Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 21:103–113CrossRef
5.
Zurück zum Zitat Chan SP, Gelding SV, McManus RJ et al (1992) Abnormalities of intermediary metabolism following a gestational diabetic pregnancy. Clin Endocrinol (Oxf) 36:417–420CrossRef Chan SP, Gelding SV, McManus RJ et al (1992) Abnormalities of intermediary metabolism following a gestational diabetic pregnancy. Clin Endocrinol (Oxf) 36:417–420CrossRef
6.
Zurück zum Zitat Catalano PM, Huston L, Amini SB, Kalhan SC (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am J Obstet Gynecol 180:903–916CrossRef Catalano PM, Huston L, Amini SB, Kalhan SC (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am J Obstet Gynecol 180:903–916CrossRef
7.
Zurück zum Zitat Xiang AH, Peters RK, Trigo E et al (1999) Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes 48:848–854CrossRef Xiang AH, Peters RK, Trigo E et al (1999) Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes 48:848–854CrossRef
8.
Zurück zum Zitat Homko C, Sivan E, Chen X, Reece EA, Boden G (2001) Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 86:568–573 Homko C, Sivan E, Chen X, Reece EA, Boden G (2001) Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 86:568–573
9.
Zurück zum Zitat Buchanan TA (2001) Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 86:989–993CrossRef Buchanan TA (2001) Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 86:989–993CrossRef
10.
Zurück zum Zitat Catalano PM, Kirwan JP, Haugel-de-Mouzon S, King J (2003) Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 133:1674S–1683SCrossRef Catalano PM, Kirwan JP, Haugel-de-Mouzon S, King J (2003) Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 133:1674S–1683SCrossRef
11.
Zurück zum Zitat Buchanan TA, Xiang TA (2005) Gestational diabetes mellitus. J Clin Invest 115:485–491CrossRef Buchanan TA, Xiang TA (2005) Gestational diabetes mellitus. J Clin Invest 115:485–491CrossRef
12.
Zurück zum Zitat Efendic S, Hanson U, Persson B, Wajngot A, Luft R (1987) Glucose tolerance, insulin release, and insulin sensitivity in normal weight women with previous gestational diabetes mellitus. Diabetes 36:413–419CrossRef Efendic S, Hanson U, Persson B, Wajngot A, Luft R (1987) Glucose tolerance, insulin release, and insulin sensitivity in normal weight women with previous gestational diabetes mellitus. Diabetes 36:413–419CrossRef
13.
Zurück zum Zitat Dornrhost A, Edwards SG, Nicholls JS et al. (1991) A defect in insulin release in women at risk of future non-insulin-dependent diabetes. Clin Sci 81:195–199CrossRef Dornrhost A, Edwards SG, Nicholls JS et al. (1991) A defect in insulin release in women at risk of future non-insulin-dependent diabetes. Clin Sci 81:195–199CrossRef
14.
Zurück zum Zitat Ward WK, Johnston CLW, Beard JC, Benedetti TJ, Halter JB, Porte D Jr (1985) Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes. Diabetes 34:861–869CrossRef Ward WK, Johnston CLW, Beard JC, Benedetti TJ, Halter JB, Porte D Jr (1985) Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes. Diabetes 34:861–869CrossRef
15.
Zurück zum Zitat Kautzky-Willer A, Prager R, Waldhausl W et al (1997) Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20:1717–1723CrossRef Kautzky-Willer A, Prager R, Waldhausl W et al (1997) Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20:1717–1723CrossRef
16.
Zurück zum Zitat Kousta E, Lawrence N, Godsland IF et al (2003) Insulin resistance and b-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol 59:289–297CrossRef Kousta E, Lawrence N, Godsland IF et al (2003) Insulin resistance and b-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol 59:289–297CrossRef
17.
Zurück zum Zitat Kirvan JP, Huston-Presley L, Kalhan SC, Catalano PM (2001) Clinically useful estimates of insulin sensitivity during pregnancy. Diabetes Care 24:1602–1607CrossRef Kirvan JP, Huston-Presley L, Kalhan SC, Catalano PM (2001) Clinically useful estimates of insulin sensitivity during pregnancy. Diabetes Care 24:1602–1607CrossRef
18.
Zurück zum Zitat Ryan EA, Imes SH, Liu D et al (1995) Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44:506–512CrossRef Ryan EA, Imes SH, Liu D et al (1995) Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44:506–512CrossRef
19.
Zurück zum Zitat Lencioni C, Volpe L, Miccoli R et al (2006) Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes. Nutr Metab Cardiovasc Dis 16:485–493CrossRef Lencioni C, Volpe L, Miccoli R et al (2006) Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes. Nutr Metab Cardiovasc Dis 16:485–493CrossRef
20.
Zurück zum Zitat Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548CrossRef Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548CrossRef
21.
Zurück zum Zitat Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51(Suppl 1):S221–S226CrossRef Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51(Suppl 1):S221–S226CrossRef
22.
Zurück zum Zitat Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166CrossRef Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166CrossRef
23.
Zurück zum Zitat Ferrannini E, Mari A (2004) Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 47:943–956CrossRef Ferrannini E, Mari A (2004) Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 47:943–956CrossRef
24.
Zurück zum Zitat Seghieri G, De Bellis A, Anichini R, Alviggi L, Franconi F, Breschi MC (2005) Does parity increase insulin resistance during pregnancy? Diabet Med 22:1574–1580CrossRef Seghieri G, De Bellis A, Anichini R, Alviggi L, Franconi F, Breschi MC (2005) Does parity increase insulin resistance during pregnancy? Diabet Med 22:1574–1580CrossRef
Metadaten
Titel
Influence of gestational diabetes on the long-term control of glucose tolerance
verfasst von
G. Seghieri
F. Tesi
R. Anichini
A. De Bellis
E. Barsotti
A. Mari
E. Ferrannini
Publikationsdatum
01.11.2007
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 11/2007
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0802-1

Weitere Artikel der Ausgabe 11/2007

Diabetologia 11/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.